Harbor Capital Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,747
| Closed | -$374K | – | 1427 |
|
|
2024
Q4 | $374K | Buy |
30,747
+9,385
| +44% | +$114K | 0.02% | 595 |
|
|
2024
Q3 | $358K | Buy |
21,362
+3,881
| +22% | +$65K | 0.02% | 616 |
|
|
2024
Q2 | $305K | Buy |
17,481
+4,941
| +39% | +$86.2K | 0.02% | 606 |
|
|
2024
Q1 | $214K | Sell |
12,540
-1,923
| -13% | -$32.8K | 0.03% | 587 |
|
|
2023
Q4 | $147K | Buy |
14,463
+4,197
| +41% | +$42.8K | 0.03% | 393 |
|
|
2023
Q3 | $92.9K | Sell |
10,266
-3,628
| -26% | -$32.8K | 0.02% | 421 |
|
|
2023
Q2 | $149K | Buy |
+13,894
| New | +$149K | 0.03% | 395 |
|